Status:
COMPLETED
Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Conditions:
Cardiac Pacing
Pacing Therapy
Eligibility:
All Genders
18-80 years
Brief Summary
This is a multi-site, non-randomized, data collection study. The purpose of this study is to investigate the cardiac electrical and mechanical function during LBBAP with different AV intervals.
Detailed Description
Left bundle branch pacing (LBBP), achieved via trans-septal approach with the pacing tip at the left side of the ventricular septum, has recently initiated and been well practiced in China. LBBP is ch...
Eligibility Criteria
Inclusion
- Patients aged from 18 to 80 years old
- Patients who are willing to provide Informed Consent
- Patients who received LBBAP for at least 3 months
- Patients' implanted device can provide intracardiac electrograms
- Bradycardia patients with AVB or heart failure patients with LBBB
Exclusion
- Patients who are pregnant or have a plan for pregnancy during the study
- Patients with persistent AF
- Patients who have medical conditions that would limit study participation
- Patients who were already enrolled in other clinical trial which would impact his/her participation
Key Trial Info
Start Date :
December 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 8 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04738396
Start Date
December 29 2020
End Date
December 8 2022
Last Update
February 21 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital
Beijing, Beijing Municipality, China, 100037
2
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China, 200030
3
Zhejiang Greentown Cardiovascular Hospital
Hangzhou, Zhejiang, China, 310011
4
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China, 310020